Biotalys has entered into a strategic partnership with 21st.BIO to accelerate the production of Biotalys' protein-based biocontrol solutions. Biotalys indicated that this collaboration will leverage 21st.BIO's proprietary fermentation platform to support the production of Biotalys' AGROBODY agricultural biocontrol products at commercially competitive costs. We regret that Biotalys and Novonesis will conclude their collaboration (in line with the transition to this new agreement). Biotalys wil...
Onward announced the appointment of a new CFO, Ali Kiboro. Mr. Kiboro brings more than 25 years of financial experience to Onward. He joins Onward from AliveDx where he served as Chief Financial Officer, leading the company's financial strategy, capital markets activities, and operational transformation. Prior to AliveDx, Ali held a variety of senior financial leadership roles at Quest Diagnostics and General Motors. Ali holds an MBA in Finance from The Wharton School and a Bachelor of Science i...
ARGAN reported FY25 EPRA net profit at €154.8m vs. our expectation of 153.3m. Argan already reported its annual rental income of €212.0m rental income in FY25, up 7% from FY24. Outlook FY26 guides for a Rental Income at 220m vs. 217m expected. The FY26 EPRA EPS is guided to approx. €6 vs. €6.04 expected. Argan plans 2 tranches of bond issues between April and October for a total between €500m and 700m. A “bridge to bond” has been agreed till November 2027 to relieve pressure (at a cost). The CF...
ONWARD Medical Appoints Ali Kiboro as Chief Financial Officer EINDHOVEN, the Netherlands, Jan. 23, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore movement, function, and independence, today announces the appointment of Ali Kiboro as Chief Financial Officer, effective January 2026. Ali brings more than 25 years of financial leadership experience across medical technology, tools and diagnostics, and general industry. He joins ONWARD Medical from AliveDx (formerly Quotient Lim...
ARGAN: 2025 annual results - An exceptional year! Annual results – Neuilly-sur-Seine, Thursday, January 22, 2026 – 5.45 pm 2025: An exceptional year Rental income: +7% Recurring net income: +13% Portfolio: €4bn excl. duties, +4% Strong increase in financial results Rental income: +7% at €212 million, annual target exceeded1Group share recurring net income: +13% at €155 million, i.e. €6.0 per share, annual target exceeded 1 Group share consolidated net income (IFRS): €245 million, including a positive fair value impact of €91 million A PREMIUM portfolio of €4Bn €220 million in invest...
ARGAN : Résultats annuels 2025 - Une année exceptionnelle ! Résultats annuels – Neuilly-sur-Seine, jeudi 22 janvier 2026 - 17h45 2025 : Une année exceptionnelle Revenus locatifs : +7 % Résultat net récurrent : +13 % Patrimoine : 4 Md€ hd, +4 % Forte progression des résultats financiers Revenus locatifs : +7% à 212 M€, objectif annuel dépassé1Résultat net récurrent part du Groupe : +13% à 155 M€, soit 6,0 € par action, objectif annuel dépassé1 Résultat net consolidé (IFRS) part du Groupe : 245 M€, comprenant un impact positif de juste valeur de 91 M€ Un patrimoine PREMIUM de 4 Md€ 22...
Onward announced the successful 6th and 7th implants of its brain-computer interface (BCI) device in two additional spinal cord injury (SCI) patients, bringing the total number of human implants to seven. Onward's ARC-BCI effectively combines its proprietary implantable ARC-IM technology to affect movement and function with Clinatec's pioneering BCI device for thought-steered control, and we believe the joint technology could trigger a major step forward for patients suffering from spinal cord i...
ONWARD Medical Completes Two Additional Brain-Computer Interface Implants Paired with Spinal Cord Stimulation Technology to Restore Thought-Driven Movement Investigational ARC-BCI® Therapy is being developed to restore thought-driven movement in people living with spinal cord injuries and other movement disabilitiesARC-BCI is the world’s first and most advanced purpose-designed platform pairing a brain-computer interface with an implantable spinal cord stimulation system Seven study participants have now received ARC-BCI Therapy to restore movement of their own paralyzed limbs EINDHOVEN, t...
ARGAN: MS. LAURENCE BATLLE JOINS ARGAN’S SUPERVISORY BOARD Press release – Neuilly-sur-Seine, Monday, January 19, 2026 – 6.30 pm Ms. Laurence BATLLE joins ARGAN’s Supervisory Board At the meeting of the Supervisory Board held on December 9, 2025, and as a result of the signing of an employment contract between the Company and Mr. Eric DONNET effective from January 2, 2026, it was acknowledged that Mr. Eric DONNET no longer met all of the independence criteria set out in the Middlenext corporate governance code to which the Company refers, and therefore ceased to be considered independent...
ARGAN : MADAME LAURENCE BATLLE INTÈGRE LE CONSEIL DE SURVEILLANCE D’ARGAN Communiqué de presse – Neuilly-sur-Seine, lundi 19 janvier 2026 - 18h30 Madame Laurence BATLLE intègre le Conseil de surveillance d’ARGAN Lors de la séance du Conseil de Surveillance du 9 décembre 2025, et en conséquence de la signature d’un contrat de travail entre la Société et Monsieur Eric DONNET à compter du 2 janvier 2026, il a été acté que Monsieur Eric DONNET ne remplissait plus l’ensemble des critères d’indépendance énoncés par le code de gouvernement d’entreprise Middlenext auquel la Société se réfère, et...
La stabilisation des taux d’intérêt et de l’inflation devrait créer un climat plus favorable à l’investissement et permettre aux sociétés immobilières de poursuivre la mise en œuvre de leur feuille de route tout en faisant preuve de prudence. Dans ce contexte, le commerce et la logistique nous semblent les mieux positionnés et nous privilégions CTP, Merlin Properties, Shurgard, URW, VGP comme les plus à même d’exécuter leur stratégie de croissance. Nous relevons notre opinion à Surperformance su...
With stabilising interest rates and inflation creating a more favourable climate for investment, the stocks in our coverage universe should be able to continue to implement their roadmaps, while remaining cautious. On this basis, we think retail and logistics are the best positioned, and see CTP, Merlin Properties, Shurgard, URW and VGP as the best placed to execute their growth strategies. We are upgrading WDP, Safestore and Instone, to Outperform, downgrading Big Yellow, Colonial-SFL, INEA, L...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.